TELERA-Asynchronous TELEmedicine for Patients With Rheumatoid Arthritis: Study Protocol for a Prospective, Multi-Center, Randomized Controlled Trial
Standard
TELERA-Asynchronous TELEmedicine for Patients With Rheumatoid Arthritis: Study Protocol for a Prospective, Multi-Center, Randomized Controlled Trial. / Mucke, Johanna; Knitza, Johannes; Muehlensiepen, Felix; Grahammer, Manuel; Stenzel, Ramona; Simon, David; Kleyer, Arnd; Krönke, Gerhard; Sharp, Charlotte; Bendzuck, Gerlinde; Korinth, Marianne; Elling-Audersch, Corinna; Vuillerme, Nicolas; Schett, Georg; Pecher, Ann-Christin; Krusche, Martin.
In: FRONT MED-LAUSANNE, Vol. 8, 2021, p. 791715.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - TELERA-Asynchronous TELEmedicine for Patients With Rheumatoid Arthritis: Study Protocol for a Prospective, Multi-Center, Randomized Controlled Trial
AU - Mucke, Johanna
AU - Knitza, Johannes
AU - Muehlensiepen, Felix
AU - Grahammer, Manuel
AU - Stenzel, Ramona
AU - Simon, David
AU - Kleyer, Arnd
AU - Krönke, Gerhard
AU - Sharp, Charlotte
AU - Bendzuck, Gerlinde
AU - Korinth, Marianne
AU - Elling-Audersch, Corinna
AU - Vuillerme, Nicolas
AU - Schett, Georg
AU - Pecher, Ann-Christin
AU - Krusche, Martin
N1 - Copyright © 2021 Mucke, Knitza, Muehlensiepen, Grahammer, Stenzel, Simon, Kleyer, Krönke, Sharp, Bendzuck, Korinth, Elling-Audersch, Vuillerme, Schett, Pecher and Krusche.
PY - 2021
Y1 - 2021
N2 - Innovative strategies are needed to adequately assess and monitor disease activity of patients with rheumatoid arthritis (RA) in times of scarce appointments. The aim of the TELERA study is to evaluate the feasibility and performance of asynchronous telemedicine visits based on patient-generated data and patient's drug history. RA patients use a medical app, ABATON, that captures the results of a self-performed quick CRP-test, joint-count, and electronic patient-reported outcomes in between visits. This is a prospective, multi-center, randomized controlled trial performed in four German university centers. The estimated sample size is 120 patients. The main outcome is the agreement of rheumatologists' treatment decisions based on asynchronous telemedicine patient-generated data with traditional in-person rheumatology clinic-based decisions and with patient suggestions. The TELERA trial will provide evidence regarding the implementation of remote care in rheumatology. Clinical Trial Registration: This clinical trial was registered at German Registry for Clinical Trials (DRKS). http://www.drks.de/DRKS00016350, identifier: DRKS00024928.
AB - Innovative strategies are needed to adequately assess and monitor disease activity of patients with rheumatoid arthritis (RA) in times of scarce appointments. The aim of the TELERA study is to evaluate the feasibility and performance of asynchronous telemedicine visits based on patient-generated data and patient's drug history. RA patients use a medical app, ABATON, that captures the results of a self-performed quick CRP-test, joint-count, and electronic patient-reported outcomes in between visits. This is a prospective, multi-center, randomized controlled trial performed in four German university centers. The estimated sample size is 120 patients. The main outcome is the agreement of rheumatologists' treatment decisions based on asynchronous telemedicine patient-generated data with traditional in-person rheumatology clinic-based decisions and with patient suggestions. The TELERA trial will provide evidence regarding the implementation of remote care in rheumatology. Clinical Trial Registration: This clinical trial was registered at German Registry for Clinical Trials (DRKS). http://www.drks.de/DRKS00016350, identifier: DRKS00024928.
U2 - 10.3389/fmed.2021.791715
DO - 10.3389/fmed.2021.791715
M3 - SCORING: Journal article
C2 - 34966765
VL - 8
SP - 791715
JO - FRONT MED-LAUSANNE
JF - FRONT MED-LAUSANNE
SN - 2296-858X
ER -
